Microbicides – Talk Bio

AI-Driven Discovery Unveils Novel Antimicrobial Proteins Effective Against Bacterial and Fungal Infections in Mice

2 months ago talkbio0Tagged Artificial Intelligence, Bacterial Infections, Drug Discovery, in vivo studies, Microbicides, Mycoses, Peptides, protein compounds

Artificial intelligence, protein compounds, antimicrobial peptides, drug discovery, bacterial infections, fungal infections, in vivo studies

FDA Approves Iterum’s Orlynvah for Uncomplicated UTIs, Offering New Hope for Patients with Limited Treatment Options

6 months ago talkbio0Tagged Approved, Iterum, Microbicides, oral antibiotic, Orlynvah, Resistance (Psychotherapeutic), United States Food and Drug Administration, Urinary tract infection, uUTIs

Iterum Therapeutics, Orlynvah, FDA approval, uncomplicated urinary tract infections (uUTIs), oral antibiotic, sulopenem, antimicrobial resistance

FDA Advisors Seek Narrower Indication for Iterum’s Oral Sulopenem in Treating Uncomplicated Urinary Tract Infections

8 months ago talkbio0Tagged AMDAC, Iterum, Microbicides, oral sulopenem, Resistance (Psychotherapeutic), United States Food and Drug Administration, Urinary tract infection, uUTIs

FDA, Iterum Therapeutics, oral sulopenem, uncomplicated urinary tract infections (uUTIs), antimicrobial resistance, Antimicrobial Drugs Advisory Committee (AMDAC)

WHO Publishes First Guidance to Combat Antibiotic Pollution from Manufacturing

8 months ago talkbio0Tagged Administration occupational activities, AMR, antibiotic pollution, Antimicrobial Resistance, Environmental Health, Microbicides, pharmaceutical manufacturing, solid waste management, Wastewater, World Health Organization

WHO, antibiotic pollution, antimicrobial resistance (AMR), wastewater management, solid waste management, pharmaceutical manufacturing, environmental health

Lilly Collaborates with OpenAI to Develop Novel Antibiotics Against Drug-Resistant Pathogens

10 months ago talkbio0Tagged Antibiotics, Drug Industry, drug-resistant, Eli Lilly, Generative AI, Microbicides, OpenAI, pathogens, Resistance (Psychotherapeutic)

Lilly, OpenAI, Antibiotics, Antimicrobial Resistance, Drug-Resistant Pathogens, Generative AI, Pharmaceutical Industry

Novo, Gates, and Wellcome Join Forces with $300 Million Initiative to Tackle Global Infectious Diseases

12 months ago talkbio0Tagged Collaboration, Communicable Diseases, development aspects, Global Health, Holdings, Melinda, Microbicides, pandemic preparedness, research, Resistance (Psychotherapeutic), Trust (Social Behavior), Wellcome

Novo Holdings, Bill & Melinda Gates Foundation, Wellcome Trust, infectious diseases, global health, pandemic preparedness, antimicrobial resistance, research and development, funding, collaboration.

US Drug Shortages Hit Record High Since 2001: ASHP Report

1 year ago talkbio0Tagged ASHP, Attention deficit hyperactivity disorder, Biden administration, Central Nervous System Stimulants, Chemotherapy Drugs Adminstered, controlled substance, Defense Production Act, DPA, Drug Enforcement Administration, Drug shortages, hormone agents, Hospitals, Incentives, intravenous fluids, Microbicides, Quality concerns, Record high, American Society of Health-System Pharmacists, shortage, Supply Chain Resilience, White House Council

Drug shortages, Record high, American Society of Health-System Pharmacists (ASHP), 323 drugs in shortage, Chemotherapy drugs, ADHD therapies, Central nervous system stimulants, Antimicrobials, Hormone agents, Intravenous fluids, Drug Enforcement Administration (DEA), Biden administration, White House Council on Supply Chain Resilience, Defense Production Act (DPA), Incentives for hospitals, Quality concerns, Controlled substances